Nitric oxide (NO) and peroxynitrite, formed from NO and superoxide ani
on, have been implicated as mediators of neuronal damage following foc
al ischemia, but their molecular targets have not been defined. One ca
ndidate pathway is DNA damage leading to activation of the nuclear enz
yme, poly(ADP-ribose) polymerase (PARP), which catalyzes attachment of
ADP ribose units from NAD to nuclear proteins following DNA damage. E
xcessive activation of PARP can deplete NAD and ATP, which is consumed
in regeneration of NAD, leading to cell death by energy depletion. We
show that genetic disruption of PARP provides profound protection aga
inst glutamate-NO-mediated ischemic insults in vitro and major decreas
es in infarct volume after reversible middle cerebral artery occlusion
. These results provide compelling evidence for a primary involvement
of PARP activation in neuronal damage following focal ischemia and sug
gest that therapies designed towards inhibiting PARP may provide benef
it in the treatment of cerebrovascular disease.